Investment analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a note issued to investors on Monday. The firm set a “buy” rating on the stock.
Mannatech Stock Performance
Shares of MTEX opened at $12.65 on Monday. Mannatech has a 52-week low of $6.75 and a 52-week high of $15.83. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. The firm has a market cap of $23.85 million, a price-to-earnings ratio of -15.62 and a beta of 1.04. The business’s 50 day moving average is $10.78 and its two-hundred day moving average is $8.62.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) earnings per share (EPS) for the quarter. The company had revenue of $31.73 million during the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Stories
- Five stocks we like better than Mannatech
- What is the FTSE 100 index?
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- 3 Best Fintech Stocks for a Portfolio Boost
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
